9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NMTR | AMGN | BMY | VRTX | GILD |
| Company | 9 Meters Biopharma Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.1103 | 277.00 | 59.88 | 462.86 | 93.81 |
| High | 0.1127 | 281.38 | 60.09 | 468.51 | 94.39 |
| Low | 0.0715 | 276.50 | 58.63 | 455.01 | 92.46 |
| Last | 0.0722 | 278.32 | 58.69 | 456.97 | 92.49 |
| Change | -0.0544 | +0.22 | -1.25 | -8.76 | -1.53 |
| % Change | -42.97% | +0.08% | -2.09% | -1.88% | -1.63% |
| Volume | 9,957,800 | 5,468,800 | 8,763,400 | 1,181,800 | 5,532,400 |
| 20-Day Average Volume | 1,667,300 | 4,423,895 | 11,512,285 | 1,419,100 | 7,375,935 |
| Previous Close | 0.1266 | 278.10 | 59.94 | 465.73 | 94.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5085 | 295.71 | 57.83 | 475.02 | 91.95 |
| 20-Day Raw Stochastic | 0.11% | 29.13% | 66.39% | 15.99% | 50.00% |
| 20-Day Relative Strength | 13.20% | 33.93% | 59.31% | 44.08% | 57.93% |
| Weighted Alpha | -89.19 | -4.54 | +25.76 | +20.59 | +26.48 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Buy | 8% Sell | 100% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 100% Buy | 8% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -62.97% since 07/18/23 | -5.33% since 11/25/24 | -0.15% since 11/25/24 | -1.03% since 11/25/24 | +2.21% since 11/25/24 |
| Low | 0.0715 on 07/25/23 | 257.80 on 11/26/24 | 58.06 on 11/26/24 | 455.01 on 12/03/24 | 89.63 on 11/26/24 |
| High | 0.1900 on 07/19/23 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 470.93 on 11/29/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | -89.24% since 06/23/23 | -12.81% since 11/01/24 | +8.04% since 11/01/24 | -3.00% since 11/01/24 | +3.33% since 11/01/24 |
| Low | 0.0715 on 07/25/23 | 257.80 on 11/26/24 | 53.97 on 11/08/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.7138 on 07/05/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -93.06% since 04/25/23 | -15.79% since 09/03/24 | +16.17% since 09/03/24 | -3.94% since 09/03/24 | +16.05% since 09/03/24 |
| Low | 0.0715 on 07/25/23 | 257.80 on 11/26/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 77.74 on 09/05/24 |
| High | 1.0700 on 04/26/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -96.69% since 01/25/23 | -9.47% since 06/03/24 | +40.51% since 06/03/24 | -2.81% since 06/03/24 | +45.81% since 06/03/24 |
| Low | 0.0715 on 07/25/23 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 |
| High | 2.6281 on 02/08/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,035 | 149,487,936 | 121,568,928 | 119,938,976 | 117,173,920 |
| Shares Outstanding, K | 14,336 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -43,770,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -13,870,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.36 | 0.55 | 0.45 | 0.36 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.02 on 05/15/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 08/21/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.72 | 50.62 | 0.00 | 20.90 |